UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Donepezil for mild cognitive impairment

Cochrane database of systematic reviews, 2006-07 (3), p.CD006104

2006

Volltextzugriff (PDF)

Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis

The New England journal of medicine, 2021-09, Vol.385 (14), p.1280-1291

2021

Volltextzugriff (PDF)

Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD

The New England journal of medicine, 2016-06, Vol.374 (23), p.2222-2234

2016

Volltextzugriff (PDF)

Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis

The New England journal of medicine, 2016-05, Vol.374 (18), p.1754-1762

2016

Volltextzugriff (PDF)

Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis

Journal of Alzheimer's disease, 2014-01, Vol.41 (2), p.615-631

2014

Volltextzugriff (PDF)

Results From the First‐in‐Human Study With Ozanimod, a Novel, Selective Sphingosine‐1‐Phosphate Receptor Modulator

Journal of clinical pharmacology, 2017-08, Vol.57 (8), p.988-996

2017

Volltextzugriff (PDF)

Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease

The New England journal of medicine, 2012-03, Vol.366 (10), p.893-903

2012

Volltextzugriff (PDF)

Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study

The lancet respiratory medicine, 2013-05, Vol.1 (3), p.199-209

2013

Volltextzugriff (PDF)

Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol–fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group study

The lancet respiratory medicine, 2013-03, Vol.1 (1), p.51-60

2013

Volltextzugriff (PDF)

Safety and efficacy of idalopirdine, a 5-HT6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial

Lancet neurology, 2014-11, Vol.13 (11), p.1092-1099

2014

Volltextzugriff (PDF)

Phase III Randomized, Placebo-Controlled Clinical Trial of Donepezil for Treatment of Cognitive Impairment in Breast Cancer Survivors After Adjuvant Chemotherapy (WF-97116)

Journal of clinical oncology, 2024-07, Vol.42 (21), p.2546-2557

2024

Volltextzugriff (PDF)

A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease

The New England journal of medicine, 2009-09, Vol.361 (13), p.1268-1278

2009

Volltextzugriff (PDF)

Cardiovascular Safety of Ozanimod in Patients With Ulcerative Colitis: True North and Open-Label Extension Analyses

Clinical gastroenterology and hepatology, 2024-05, Vol.22 (5), p.1067-1076.e3

2024

Volltextzugriff (PDF)

Randomized trial of preladenant, given as monotherapy, in patients with early Parkinson disease

Neurology, 2017-06, Vol.88 (23), p.2198-2206

2017

Volltextzugriff (PDF)

LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD

International journal of chronic obstructive pulmonary disease, 2015-01, Vol.10 (Issue 1), p.1015-1026

2015

Volltextzugriff (PDF)

The efficacy and safety of memantine for the treatment of Alzheimer's disease

Expert opinion on drug safety, 2018-10, Vol.17 (10), p.1053-1061

2018

Volltextzugriff (PDF)

Adverse Effects of Cholinesterase Inhibitors in Dementia, According to the Pharmacovigilance Databases of the United-States and Canada

PloS one, 2015-12, Vol.10 (12), p.e0144337

2015

Volltextzugriff (PDF)

Characterization of Negative Allosteric Modulators of the Calcium-Sensing Receptor for Repurposing as a Treatment of Asthma

The Journal of pharmacology and experimental therapeutics, 2021-01, Vol.376 (1), p.51-63

2021

Volltextzugriff (PDF)

Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment

The New England journal of medicine, 2005-06, Vol.352 (23), p.2379-2388

2005

Volltextzugriff (PDF)

Long-term effects of rasagiline and the natural history of treated Parkinson's disease

Movement disorders, 2016-10, Vol.31 (10), p.1489-1496

2016

Volltextzugriff (PDF)

TV 3326 for Alzheimer’s dementia: a novel multimodal ChE and MAO inhibitors to mitigate Alzheimer’s‐like neuropathology

Journal of pharmacy and pharmacology, 2020-08, Vol.72 (8), p.1001-1012

2020

Volltextzugriff (PDF)

Sponging off nature for new drug leads

Biochemical pharmacology, 2017-09, Vol.139, p.3-14

Andersen, Raymond J.

2017

Volltextzugriff (PDF)

Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD

The European respiratory journal, 2011-10, Vol.38 (4), p.797-803

2011

Volltextzugriff (PDF)

A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease

Journal of Alzheimer's disease, 2013-01, Vol.35 (2), p.349-361

2013

Volltextzugriff (PDF)

Efficacy and safety of once-daily QVA149 compared with the free combination of once-daily tiotropium plus twice-daily formoterol in patients with moderate-to-severe COPD (QUANTIFY): a randomised, non-inferiority study

Thorax, 2015-04, Vol.70 (4), p.311-319

2015

Volltextzugriff (PDF)

1 – 25 von 896

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(809)
Mit Volltextzugriff
(627)

Publikationsform

Sprache

9 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(828)
Science & Technology
(729)
Indans - Adverse Effects
(726)
Life Sciences & Biomedicine
(722)
Male
(515)
Indans - Therapeutic Use
(496)
Female
(464)
Aged
(434)
Piperidines - Adverse Effects
(430)
Cholinesterase Inhibitors - Adverse Effects
(332)
Piperidines - Therapeutic Use
(327)
Middle Aged
(301)
Alzheimer Disease - Drug Therapy
(285)
Indans - Administration & Dosage
(266)
Donepezil
(257)
Cholinesterase Inhibitors - Therapeutic Use
(244)
Treatment Outcome
(244)
Pharmacology & Pharmacy
(235)
Biological And Medical Sciences
(227)
Medical Sciences
(218)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Donepezil for mild cognitive impairment

Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis

Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD

Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis

Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis

Results From the First‐in‐Human Study With Ozanimod, a Novel, Selective Sphingosine‐1‐Phosphate Receptor Modulator

Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease

Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study

Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol–fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group study

Safety and efficacy of idalopirdine, a 5-HT6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial

Phase III Randomized, Placebo-Controlled Clinical Trial of Donepezil for Treatment of Cognitive Impairment in Breast Cancer Survivors After Adjuvant Chemotherapy (WF-97116)

A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease

Cardiovascular Safety of Ozanimod in Patients With Ulcerative Colitis: True North and Open-Label Extension Analyses

Randomized trial of preladenant, given as monotherapy, in patients with early Parkinson disease

LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD

The efficacy and safety of memantine for the treatment of Alzheimer's disease

Adverse Effects of Cholinesterase Inhibitors in Dementia, According to the Pharmacovigilance Databases of the United-States and Canada

Characterization of Negative Allosteric Modulators of the Calcium-Sensing Receptor for Repurposing as a Treatment of Asthma

Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment

Long-term effects of rasagiline and the natural history of treated Parkinson's disease

TV 3326 for Alzheimer’s dementia: a novel multimodal ChE and MAO inhibitors to mitigate Alzheimer’s‐like neuropathology

Sponging off nature for new drug leads

Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD

A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease

Efficacy and safety of once-daily QVA149 compared with the free combination of once-daily tiotropium plus twice-daily formoterol in patients with moderate-to-severe COPD (QUANTIFY): a randomised, non-inferiority study

Suchergebnisse filtern